Technology Evaluation Consortium (TEC)

Pharmaceutical companies working in partnership with technology providers

Benefits of Technology Evaluation Consortia:

The program provides technology sponsors with a channel to reach multiple pharmaceutical companies simultaneously. By leveraging a shared library of proprietary compounds (with correlated in vivo data) created by the pharma companies, technology innovators are able to further quaify their platforms.

More than 33% of participting pharma companies purchase/lease the technology or service following completion of the Technology Evaluation Consortium.
Member companies, making up Technology Evalution team, provide direct input into the technology sponsor's produt design and/or business model.
The term of Technology Evalution Consortia is typicaly 3-6 months

View our current projects

View case studies of past CHA projects